Karani Asset Management’s Health Catalyst HCAT Stock Holding History
Bought
Maintained
Sold
Other funds holding HCAT
RP
Karani Asset Management's HCAT Position: Q1 2022 in Review
Karani Asset Management sold out of Health Catalyst (HCAT) in Q1 2022, closing a stake of 14,949 shares — an estimated $592K sold.
Karani Asset Management first reported a position in HCAT in Q2 2020 and held it in 7 quarters. The position peaked at $7.09M in Q2 2021. 185 funds tracked by Wall St. Rank hold HCAT as of Q1 2022.
- Karani Asset Management reported no remaining Health Catalyst position as of Q1 2022 after selling out during the quarter.
- Karani Asset Management sold 14,949 Health Catalyst shares in Q1 2022, an estimated $592K.
- Karani Asset Management first reported a position in Health Catalyst in Q2 2020 and held it in 7 quarters.
- Karani Asset Management's Health Catalyst position peaked at $7.09M in Q2 2021.
- 185 funds tracked by Wall St. Rank held Health Catalyst as of Q1 2022.
Based on Karani Asset Management's 13F filing for Q1 2022, filed 16 May 2022.